A Manhattan jury mulled Wednesday whether to award entrepreneur Shmuel "Sam" Sherman damages after his company accused a rival of poaching what Sherman calls revolutionary software that allows resale brokers to easily reprice inventory in the multibillion-dollar market for sports and entertainment tickets.
Two boat companies that had fought for years over claims they infringed each other's trademarks found out from a Delaware federal jury Wednesday that their entire fight was for nothing — no one's trademarks were infringed at all.
The ex-husband of a former Ariad Pharmaceuticals executive was sentenced to 18 months in prison Wednesday for insider trades he made based on meetings his then-wife had with the U.S. Food and Drug Administration about the company's cancer drug.
Counsel for the widow of a manufacturing plant worker who died of mesothelioma told a New Jersey jury during closing arguments Wednesday that asbestos supplier Union Carbide Corp. caused the "worst pain and suffering" possible and should be forced to pay damages to match.
The day before hundreds of potential jurors descend on a Boston courtroom for a closely watched criminal case accusing former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, attorneys sparred Wednesday over what patients who took the drug can say during the 14-week trial.
Three former Barclays PLC traders were part of a conspiracy to cheat the financial system that “tainted” the integrity of a key interest rate benchmark used to price trillions of dollars of financial products, prosecutors told a London jury on Wednesday.
A Manhattan federal judge on Tuesday spared the founder of hedge fund manager Weston Capital Asset Management from prison over his role in a multimillion-dollar investment fraud scheme after the government cited his crucial cooperation in prosecutions that brought down film producer David Bergstein and serial fraudster Jason Galanis.
A University of California, Berkeley economics professor testified for the Federal Trade Commission on Tuesday that Qualcomm's standard-essential patent royalties serve as a competition-killing "naked tax" on its modem chips, comparing the practice to software bundling that got Microsoft in trouble with the feds 20 years ago.
The Patent Trial and Appeal Board will review an IBM Corp. e-commerce patent challenged by a group of travel websites, rejecting Tuesday the argument that it should deny the petition in light of a recent jury verdict against Groupon Inc. in a $57 million infringement dispute.
Medical device maker Greatbatch Ltd. received a $22 million damages award Monday following a six-day trial in Delaware federal court over three pacemaker technology patents infringed by AVX Corp., replacing a 2016 jury decision that awarded it $37.5 million.
A Minnesota appeals court on Monday affirmed a $4.7 million verdict for a driver who was seriously hurt when a rock from a construction company’s truck smashed into his vehicle, and said the lower court needs to consider putting punitive damages back on the table.
The Eleventh Circuit on Tuesday vacated an injury award in a suit blaming the federal government for injuries a NASA civilian employee suffered in an auto collision due to a U.S. Army base security guard’s alleged negligence, saying the government is immune to liability under the Federal Tort Claims Act.
Westinghouse Air Brake Technologies Corp. on Tuesday called a battery of Siemens Mobility Inc. patent infringement claims "desperate" gambits by a latecomer to the U.S. rail safety market, during opening statements in Delaware for a nine-day $8.3 million federal jury trial.
A state judge in Pittsburgh awarded “quadruple damages” against Ameriprise Financial Inc. based on an erroneous reading of Pennsylvania law and wrongly handed out attorneys’ fees that had ballooned during appeal, the company told a state Superior Court panel Tuesday in a life insurance overpayment dispute.
A Massachusetts federal jury convicted a former Georgeson LLC adviser on fraud and conspiracy charges Tuesday afternoon, delivering a win for prosecutors who claimed the adviser participated in a scheme to swap sports tickets for confidential shareholder voting data after their first bid to convict her ended in a mistrial.
Prosecutors opened their second trial in London on Tuesday of three former Barclays PLC employees accused of participating in a conspiracy to rig global interest rates to rip off counterparties that did business with them.
Chemical company Union Carbide told a New Jersey jury during Monday closing arguments that a manufacturing plant worker's fatal mesothelioma couldn't have been caused by the asbestos it supplied to his employer, because there was no evidence the man ever worked with or around that asbestos.
A Florida-based securities attorney was a central figure in a plot to defraud investors who bought penny stock in a company involved in hydroponic marijuana growing equipment, prosecutors told a Colorado federal jury Monday at the start of his trial.
A Florida federal jury on Monday handed down a $21.5 million verdict against Park Hotels & Resort, formerly known as Hilton Worldwide Inc., in a suit brought by a dishwasher alleging religious discrimination when she was fired after refusing to work on a Sunday.
Jones Walker LLP has absorbed the founding partner of fellow New Orleans-anchored international dispute firm Fowler Rodriguez, along with a group of attorneys versed in working with domestic and international maritime, energy and insurance clients on issues including infrastructure deals, immigration, tax matters, mergers and acquisitions, and international arbitration.
While several proposed changes to multidistrict litigation procedures may be warranted and appropriate, consideration should be given to a modest modification of the judicial selection process, says Doug Smith of Kirkland & Ellis LLP.
Judge Jack Weinstein has served in the Eastern District of New York for over half a century. White and Williams LLP attorney Randy Maniloff visited his Brooklyn office to find out what makes the 97-year-old jurist tick.
2018 will be remembered as a transition year for technology-assisted review, and 2019 will likely see a continued focus on how we use TAR, with refinement and expansion across the board, says Thomas Gricks of Catalyst Repository Systems LLC.
Last year saw significant litigation over clinical trials, as well as new proposed guidance from the U.S. Food and Drug Administration about how such trials ought to be performed — guidance that could become important in future litigation, say Sheryl Bjork and William Childs of Bowman and Brooke LLP.
Last year saw another round of year-over-year growth in litigation finance, as debates shifted from whether it should be permitted to how it can best be managed. The exciting news, says Alan Guy of Vannin Capital PCC, is that 2019 seems likely to bring more of the same.
Leveraging technology in a fiercely competitive market is a key factor driving law firms toward technology adoption in 2019, as they face growing demand from legal talent and clients for the ability to connect, access and control information whenever and wherever needed, says Tomas Suros of tech provider AbacusNext.
Last year, rulings by multiple federal courts reduced fiduciaries' accountability to retirement plan participants. But litigation and regulatory developments in the coming year may ensure that participants harmed by fiduciary misconduct find fewer hurdles to recovery, say Karen Handorf and Daniel Sutter of Cohen Milstein Sellers & Toll PLLC.
Law360 guest authors weighed in on a host of key legal industry issues this year, ranging from in-house tips for success and open secrets about BigLaw diversity to criticisms of the equity partnership and associate salary models. Here are five articles that captured the most attention.
Take a peek behind the scenes of four U.S. Supreme Court cases from 2018, as the attorneys who won them reflect on the challenges they faced and the decisions they made that led to victory.
Denmark's product liability law does not allow for punitive damages. But specific legislation does improve the chances of plaintiffs being compensated for personal injury caused by drugs or medical devices, say attorneys with the Danish law firm Poul Schmith.